Notice is hereby given that in pursuance of SEBI (PIT) Regulations, 2015 and Company''s code of conduct for regulating, monitoring and reporting of Trading by insiders, the Trading Window ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Gennex Laboratories has informed stock exchanges that its trading window for dealing in company securities will remain closed from October 1, 2025 until 48 hours after the Board publicly announces its Un-audited Standalone and Consolidated Financial Results for the second quarter and half-year ended September 30, 2025. The closure is in line with SEBI's Prohibition of Insider Trading Regulations, 2015 and the company's internal code of conduct for insiders. The exact Board meeting date to approve these Q2/H1 FY26 results has not yet been disclosed and will be communicated later. All promoters, designated persons, and connected persons have been advised not to trade in the company's shares during this blackout period, either directly or indirectly.
This is a routine regulatory compliance announcement and does not carry any positive or negative business signal. Investors should expect the Q2/H1 FY26 results announcement in early-to-mid October 2025, which could be a potential catalyst for stock movement depending on the numbers.